Member
|
|
Join Date: Sep 2006
Posts: 629
|
|
Member
Join Date: Sep 2006
Posts: 629
|
Pharma is changing to biopharma
Because the rate at which novel compounds for "unmet" therapies, as small molecule entities, are becoming more rare to discover and market. New, effective drugs for many neurological conditions are just not coming on line. When will they get the message that nature has all the capacity for healing disease, and it exists in what we already possess, ie., cells. cs
|